Strategies to remove or block the effects of IL6 in SSc serum including immunodepletion of IL6 and the addition of an anti-IL6 blocking antibody reversed the effects of SSc serum on endothelial cell activation and apoptosis [56]. The gene discussed is IL6; the disease is systemic sclerosis.